Learn how DNA can be exchanged between two cells that connect by forming nanotubes, and find out why this is crucial for cancer research.
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained in remission far longer than those receiving standard therapies, according to results from a major international Phase III clinical trial published in The New England Journal of Medicine and presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
The study, led by senior author C. Ola Landgren, M.D., Ph.D., found nearly 70% of patients receiving teclistamab had no disease progression after 18 months—compared with about 27% of patients receiving standard treatments—while nearly two-thirds achieved complete remission, including many with no detectable cancer on highly sensitive testing.
Landgren is chief of the Sylvester Myeloma Institute at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
A feature story authored by Simon Spichak, MSc investigates how biotech companies like Cortical Labs and FinalSpark harness human brain cells to electrodes, performing computational functions and testing the cells’ responses to electrical and chemical stimuli. To create biocomputers, scientists grow organoids—small spheres of, in this case, neural tissue—on top of multi-electrode arrays in a hardware shell, which can then be used for everything from testing medications to playing video games. The work is published in the Journal of Medical Internet Research.
Researchers at the University of Toronto’s Leslie Dan Faculty of Pharmacy, working with collaborators around the world, have demonstrated the effectiveness of a suite of low-cost, portable biotechnology tools designed to improve access to laboratory research and diagnostics in resource-limited settings.
Published in Science Advances, the study highlights how decentralized biomanufacturing tools and freeze-dried reagents can help researchers produce high-value biological materials locally—reducing reliance on fragile international supply chains and expanding access to life sciences innovation globally.
The research was led by Keith Pardee, associate professor at the Leslie Dan Faculty of Pharmacy, alongside collaborators including Camila González in Bogotá, Colombia, Fernán Federici in Santiago, Chile, and Lindomar Pena in Recife, Brazil.
Scientists have developed a powerful new technique that allows them to observe how individual cells manufacture proteins during aging, offering an unprecedented glimpse into the hidden molecular activity of stem cells in living tissue. As a result of the research, conducted at the Institute for Regenerative Medicine in Switzerland, scientists were able to observe aging unfold inside individual epidermal stem cells.
What scientists saw was the intricate choreography within stem cells and how those molecular dance steps slow and change with age. The team of Swiss scientists has concluded that the process of aging reshapes how skin stem cells manufacture proteins. The findings are published in the journal Molecular Cell.
/ @lostpagesofscience.
Discover the incredible future of biohybrid robots, the revolutionary fusion of synthetic biology, artificial intelligence, and robotics! In this episode, we explore robots powered by living tissues, capable of self-repair, adaptation, and natural movements. Find out how these bioengineered robots can transform medicine, agriculture, environmental science, and prosthetics. Learn about the ethical considerations, safety challenges, and futuristic possibilities of combining biological materials with robotic systems.
🔔 Don’t forget to subscribe for cutting-edge science & technology content!
📌 Chapters:
00:00 — Introduction to Biohybrid Robots.
01:30 — What Are Biohybrid Robots?
03:50 — How Scientists Build Biohybrid Robots.
06:20 — Medical Applications & Healthcare.
08:45 — Revolutionary Prosthetics.
11:00 — Environmental Biohybrid Robotics.
13:20 — Agricultural Applications.
14:50 — Ethical & Safety Considerations.
17:00 — Future Possibilities.
19:00 — Conclusion & Call to Action.
SEO Keywords:
Biohybrid robots.
Synthetic biology and robotics.
Living robots.